T-bone1 Posted February 7, 2017 Share Posted February 7, 2017 Does anyone have any good suggestions of a well-structured and low cost fundamentally-weighted index or ETF? Thanks! Link to comment Share on other sites More sharing options...
CorpRaider Posted February 7, 2017 Share Posted February 7, 2017 U.S. RPV (not fundamental weighted in RAFI sense); FNDB (Schwab's RAFI suite is cheaper than the Powershares one, with minor tweaks to fundamentals used); DTD (cheapest ER I've seen among these @ .28 is dividend weighted). These all have 10+ years of live result track records (the RAFI results are for other funds but same index/methodology). Link to comment Share on other sites More sharing options...
PLynchJr Posted February 7, 2017 Share Posted February 7, 2017 No real opinion on it but Diamond Hill has a valuation weighted 500 ETF that has slightly out-performed the index since inception (end of 2011). Expense ratio is .10. http://www.diamond-hill.com/strategies/long-only-equities/etf/valuation-weighted-500-etf/overview/ Link to comment Share on other sites More sharing options...
sarganaga Posted February 7, 2017 Share Posted February 7, 2017 I like the approach of the AlphaDex funds by First Trust. They are not cheap with approximately .60- .80 expense ratios, but combine both value and momentum factors. This seems like too much to pay for US oriented etf's, but for the small cap emerging market etf FEMS , which I own, it seems reasonable. Here is a link for etf info https://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FEMS Link to comment Share on other sites More sharing options...
CorpRaider Posted February 7, 2017 Share Posted February 7, 2017 No real opinion on it but Diamond Hill has a valuation weighted 500 ETF that has slightly out-performed the index since inception (end of 2011). Expense ratio is .10. http://www.diamond-hill.com/strategies/long-only-equities/etf/valuation-weighted-500-etf/overview/ I track that one too but am leery of the size (~$17MM), fee waiver (going to .45% in April 2017 without extension), and also don't prefer their use of projected metrics (cash flows or earnings can't remember which) as some of the literature shows and I personally believe the value premium may largely be the result of bad predictions/recency bias. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now